跳至主要内容
临床试验/NCT02978950
NCT02978950Unknown不适用

SToP: Venous Thromboembolism Screening in the Trauma Population

Intermountain Health Care, Inc.2 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2017年3月20日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
2,000
试验地点
2
主要终点
Asymptomatic lower extremity DVT

研究概览

简要总结

This is a prospective, randomized vanguard trial of trauma patients admitted to the trauma surgery service at Intermountain Medical Center who are deemed to be at high risk for venous thromboembolism. Once identified and enrolled, subjects will be randomized to receive bilateral lower extremity duplex ultrasound surveillance versus no surveillance. The study will compare the two groups with regard to deep vein thrombosis, pulmonary embolism, and major and clinically relevant bleeding episode rates, both during the index hospitalization and at 90 days post-discharge.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Inpatient status on Intermountain Medical Center (IMC) trauma surgery service, admitted within 24 hours of injury.
  • Age ≥18 at the time of injury
  • Meets the definition of high-risk for VTE according to current IMC trauma service guidelines

排除标准

  • Patient age <18 years at the time of admission to the hospital
  • Patients with a life expectancy of less than 30 days
  • Patients with a known hypercoagulable state including:
  • Factor V Leiden
  • Protein C and S deficiencies
  • Dysfibrogenemia of any sort
  • Active cancer
  • Antiphospholipid antibody syndrome
  • History of DVT or PE within past 6 months
  • Myeloproliferative disorders
  • Patients on therapeutic anticoagulation who do not have their agent held upon admission to the hospital.
  • Patient elects to opt-out of the study

研究组 & 干预措施

Surveillance arm

Experimental

Bilateral duplex ultrasound surveillance

干预措施: Duplex ultrasound surveillance (Other)

No surveillance arm

Active Comparator

no duplex ultrasound surveillance

干预措施: No ultrasound surveillance (Other)

结局指标

主要结局

Asymptomatic lower extremity DVT

时间窗: during index hospitalization, up to 2 weeks

any DVT found in the lower extremity

次要结局

  • All cause mortality(90 days)
  • Symptomatic DVT propagation from calf veins to proximal veins(14 days from hospital discharge)
  • Symptomatic/fatal pulmonary embolism(90 days from hospital discharge)
  • Major and clinically relevant bleeding episodes(during index hospitalization, up to 2 weeks)
  • Composite outcome of proximal DVT plus major and clinically relevant bleeding episodes(during index hospitalization, up to 2 weeks)
  • Symptomatic DVT(90 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验